FBTCX Mutual Fund (Fidelity Advisor Biotechnology Fund Class C) is managed by Fidelity Investments (US) with $64.5M in net assets. FBTCX expense ratio is 1.71%, holding 84 positions across sectors including Health Care, Financials, Unknown. Inception date: 2000-12-27.

FBTCX performance shows a YTD return of 4.25%. The 1-year return is 43.53% and the 5-year return is 11.36%. FBTCX dividend yield stands at 1.30%, paid annually.

FBTCX top holdings include Abbvie Inc (16.6%), Alnylam Pharmace (7.7%), Gilead Sciences Inc (5.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.7%), Fidelity Securities Lending Cash Central Fund (4.3%). View all FBTCX holdings, sector breakdown, or dividend history.

FBTCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTCX alternatives are available via the screener, along with tax-loss harvesting opportunities.